أخبار السوق

0 0 0

المصدر: PRNewsWire وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

الرموز ذات الصلة 1

P PRCT PRCT

المصدر: PRNewsWire

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Why Okta (OKTA) Dipped More Than Broader Market Today

In the latest trading session, Okta (OKTA) closed at $143.51, marking a -2.4% move from the previous day.

الرموز ذات الصلة 1

O OKTA OKTA

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Affirm Holdings (AFRM) Registers a Bigger Fall Than the Market: Important Facts to Note

Affirm Holdings (AFRM) closed at $76.58 in the latest trading session, marking a -2.41% move from the prior day.

الرموز ذات الصلة 1

A AFRM AFRM

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

NetApp (NTAP) Increases Despite Market Slip: Here's What You Need to Know

NetApp (NTAP) closed at $191.48 in the latest trading session, marking a +2.62% move from the prior day.

الرموز ذات الصلة 1

N NTAP NTAP

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Here's Why Lithium Americas Corp. (LAC) Fell More Than Broader Market

Lithium Americas Corp. (LAC) reached $3.02 at the closing of the latest trading day, reflecting a -2.27% change compared to its last close.

الرموز ذات الصلة 1

L LAC LAC

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.28 per share a year ago.

الرموز ذات الصلة 1

T TXG TXG

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

الرموز ذات الصلة 1

Q QDEL QDEL

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.64 per share a year ago.

الرموز ذات الصلة 1

G GEN GEN

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago.

الرموز ذات الصلة 1

H HALO HALO

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates

Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.55 per share a year ago.

الرموز ذات الصلة 1

J JANX JANX

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Airbnb, Inc. (ABNB) Beats Q2 Earnings and Revenue Estimates

Airbnb, Inc. (ABNB) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.03 per share a year ago.

الرموز ذات الصلة 1

A ABNB ABNB

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $0.34 per share a year ago.

الرموز ذات الصلة 1

A ARCT ARCT

المصدر: Zacks Investment Research

Official Partner ITBFX Start Trading

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.36 per share a year ago.

الرموز ذات الصلة 1

D DOCS DOCS

المصدر: Zacks Investment Research

0 0 0

المصدر: Zacks Investment Research وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.34 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.

الرموز ذات الصلة 1

T TTD TTD

المصدر: Zacks Investment Research

0 0 0